Back to search results

Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01)

Abroad (travel likely)RecruitingPHASE2

Conditions

Lung Neoplasm Malignant

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Southern Cancer Center (SCC) ( Site 8004), Daphne, Alabama, United States

    Study coordinator · 251-607-5281

  • Sansum Clinic (Ridley Tree) ( Site 8012), Santa Barbara, California, United States

    Study coordinator · 805-879-0643

  • Rocky Mountain Cancer Centers (RMCC) ( Site 8011), Lone Tree, Colorado, United States

    Study coordinator · 303-285-5051

  • MedStar Franklin Square Medical Center ( Site 0033), Baltimore, Maryland, United States

    Study coordinator · 443-777-7147

  • Oncology Associates of Oregon, P.C.(Willamette Valley Cancer Institute) (WVCI) ( Site 8006), Eugene, Oregon, United States

    Study coordinator · 541-683-5001

  • Texas Oncology - Central/South Texas ( Site 8009), Austin, Texas, United States

    Study coordinator · 254-399-0741

  • Texas Oncology - Northeast Texas ( Site 8005), Tyler, Texas, United States

    Study coordinator · 903-579-9800

  • Virginia Cancer Specialists (VCS) ( Site 8002), Fairfax, Virginia, United States

    Study coordinator · 215-706-2034

  • Centro de Estudios Clínicos SAGA ( Site 0162), Santiago, Region M. de Santiago, Chile

    Study coordinator · +56991612199

  • FALP ( Site 0161), Santiago, Region M. de Santiago, Chile

    Study coordinator · +56224205098

  • Bradfordhill ( Site 0160), Santiago, Region M. de Santiago, Chile

    Study coordinator · +56229490970

  • Alexandra General Hospital of Athens Oncology-Hematology Unit ( Site 0203), Athens, Attica, Greece

    Study coordinator · 0030 2132142545

  • ATTIKON GENERAL UNIVERSITY HOSPITAL-Oncology ( Site 0202), Athens, Attica, Greece

    Study coordinator · 0030 2313301848

  • Metropolitan Hospital-4th Oncology Dept ( Site 0201), Athens, Attica, Greece

    Study coordinator · 0030 2104807106

  • University General Hospital of Heraklion ( Site 0200), Heraklion, Irakleio, Greece

    Study coordinator · 0030 2810392091

  • Petz Aladar Egyetemi Oktato Korhaz-Pulmonológia (Dr. Szalai Zsuzsanna) ( Site 0062), Győr, Győr-Moson-Sopron, Hungary

    Study coordinator · +3696507900

  • Jász-Nagykun-Szolnok Vármegyei Hetényi Géza Kórház-Onkologiai Kozpont ( Site 0061), Szolnok, Jász-Nagykun-Szolnok, Hungary

    Study coordinator · +3656503603

  • Országos Korányi Pulmonológiai Intézet ( Site 0060), Budapest, Hungary

    Study coordinator · +3613913200

  • Azienda Ospedaliera Universitaria Careggi ( Site 0173), Florence, Tuscany, Italy

    Study coordinator · +393209225506

  • Ospedale San Raffaele. ( Site 0171), Milan, Italy

    Study coordinator · 390223903829

  • Fondazione IRCCS Istituto Nazionale dei Tumori ( Site 0175), Milan, Italy

    Study coordinator · 390223902190

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore ( Site 0174), Roma, Italy

    Study coordinator · +390630154844

  • Wielkopolskie Centrum Pulmonologii i Torakochirurgii-Oddzial Onkologii Klinicznej z Pododdzialem Dz ( Site 0153), Poznan, Greater Poland Voivodeship, Poland

    Study coordinator · +48616654242

  • Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworow Pluca i Klatki Pier ( Site 0151), Warsaw, Masovian Voivodeship, Poland

    Study coordinator · 48225463066

  • Uniwersyteckie Centrum Kliniczne-Early Clinical Trials Unit ( Site 0150), Gdansk, Pomeranian Voivodeship, Poland

    Study coordinator · +48 58 584 44 66

  • Hospital Clinic de Barcelona ( Site 0092), Barcelona, Spain

    Study coordinator · 34 932275402

  • Baskent University Dr. Turgut Noyan Research and Training Center-ONCOLOGY ( Site 0702), Adana, Turkey (Türkiye)

    Study coordinator · 903223272727

  • Hacettepe Universite Hastaneleri-oncology hospital ( Site 0700), Ankara, Turkey (Türkiye)

    Study coordinator · +903123052941

  • Akdeniz Universitesi Hastanesi-Medical Oncology ( Site 0704), Antalya, Turkey (Türkiye)

    Study coordinator · 902422271736

  • İzmir Suat Seren Chest Disease Training & Research Hospital ( Site 0701), Izmir, Turkey (Türkiye)

    Study coordinator · 902324587262

  • Ondokuz Mayıs Universitesi-Oncology department ( Site 0706), Samsun, Turkey (Türkiye)

    Study coordinator · 903624576041

  • CNE CC of Oncology Hematol ( Site 0130), Cherkasy, Cherkasy Oblast, Ukraine

    Study coordinator · +38(0472)31-94-18

  • Municipal Enterprise "Bukovinian сlinical oncology сenter" ( Site 0139), Chernivtsi, Chernivetska Oblast, Ukraine

    Study coordinator · +380955077568

  • CNCE Precarpathian Clinical Oncologic Center ( Site 0131), Ivano-Frankivsk, Ivano-Frankivsk Oblast, Ukraine

    Study coordinator · +380978411455

  • MNPE LTMU Multidisc. Clin. Hosp. of Emerg. and Intens. Care ( Site 0132), Lviv, Lviv Oblast, Ukraine

    Study coordinator · 380977453295

  • ME RIVNE REGIONAL ANTITUMOR CENTER ( Site 0460), Rivne, Rivne Oblast, Ukraine

    Study coordinator · 380503802915

  • Communal Noncommercial Enterprise "Podillia Regional Oncology Center Of Vinnytsia Regional Council" ( Site 0135), Vinnytsia, Vinnytsia Oblast, Ukraine

    Study coordinator · 0988936318

  • Shalimov Institute of Surgery and Transplantation ( Site 0138), Kyiv, Ukraine

    Study coordinator · 093 33 33 911
Study leads

  • Medical Director

    Study Director

    Merck Sharp & Dohme LLC

View source on ClinicalTrials.gov(opens in a new tab)